Mapping the peptide audiences

Looking at the conversation through what people are actually doing, rather than which peptides they mention, gives a very different view of the craze. The biggest and most sustained behaviors are increasingly about experimentation and access. Stacking and protocols sits high in the sustained-breakout zone, while DIY and gray-market sourcing and self-injecting at home are among the fastest-moving conversations in the area.

Self-injecting at home is particularly striking. It has the biggest peak velocity of any behavior on the chart, even though its lifespan is shorter. That suggests the conversation is moving quickly from curiosity about peptides to people actively figuring out how to use them themselves. DIY and gray-market sourcing shows a similar trajectory, while biohacking and self-optimization is also growing faster than the wider peptide conversation.

At the same time, the beauty side is taking a slower, more durable route. Glass skin and brightening has one of the longest lifespans on the chart, suggesting that aesthetic language around peptides can sustain attention well beyond a viral spike. Looksmaxxing is another interesting crossover, growing faster than the wider field and connecting peptide use to a broader obsession with appearance and staying young.

The chart also shows where skepticism is settling in. Scam and “does-it-work” skepticism has a long lifespan, suggesting that questions around efficacy are becoming a persistent part of the conversation rather than a short-lived reaction. Menopause and early anti-aging sit in a similar long-lived space, showing how peptides are increasingly being framed around specific life stages and the desire to intervene earlier.

What’s emerging is that peptide culture is becoming behavioral. People are moving from talking about ingredients to discussing protocols, sourcing, injections, optimization and specific appearance goals. The fastest-growing conversations are increasingly about what people are willing to do to change how they look, feel and age.

Five of the emerging stories are big enough, and different enough, to reward a closer look: the ingredient crossing over from Korea, the breakout whose story is escalating from cream to needle, the frontier that behaves least like beauty at all, the need-state hiding in plain sight, and the sleeper beauty hit nobody has claimed yet.

The peptide audience is far from one community. When we map who is driving the conversation around peptides and how these voices connect, we see a highly fragmented landscape.

First, mapping the conversation across X and TikTok reveals two distinct worlds: X fragments into interest tribes spanning longevity, performance/optimization lads, healthcare skeptics, sports fans and traders, while TikTok brings peptides closer to mainstream consumer culture through shopping and skincare personas, following specific rational enthusiasts, K-beauty fans and millennial moms.

Different communities have developed their own narratives and interests around peptides, rather than participating in one unified conversation. Visualizing community engagement through Pulsar’s 3D influencer network makes this fragmentation immediately visible, with distinct clusters separated by distance and color.

Mapping brand reputation gives us a clearer sense of how the peptide obsession is spilling into different industries. When we rank brands by Pulsar’s Reputation Health Score, beauty dominates the top of the table, with K-beauty especially prominent. Medicube ranks first at 77, followed by L’Oréal at 76 and Rhode at 75, while five Korean skincare brands make the top 10.

What’s interesting is where Korean beauty is leading. The category is moving beyond traditional skincare and makeup towards regenerative beauty, with products increasingly promising to improve the condition of skin rather than simply cover it. Peptides and PDRN fit neatly into this shift, bringing the language of repair, regeneration and skin health into everyday beauty. Medicube’s PDRN Pink Peptide Serum is a clear example, combining two of the biggest regenerative ingredients in the conversation and pushing them into a highly visible consumer product.

The five K-beauty brands in the top 10 suggest this is bigger than any single product. Korean beauty is helping move ideas that once belonged to clinics, biohacking communities and regenerative medicine into mainstream beauty culture, as consumers become more interested in ingredients that promise to change the underlying condition of their skin.

Pharma has a harder time converting attention into reputation. Eli Lilly is the only pharma brand in the top 10, while Wegovy, Mounjaro, Novo Nordisk and Ozempic rank further down despite their enormous visibility. At the same time, some of the fastest-growing behaviors around peptides are happening outside traditional healthcare, from self-dosing and at-home injections to gray-market sourcing and DIY stacking. The gap points to something bigger than pharma brand perception: as trust in mainstream healthcare weakens, consumers are increasingly looking beyond the traditional health system for ways to manage their bodies, health and aging.

Peptides may have started in clinical and biohacking circles, but they now sit at the intersection of two very different ideas about health. K-beauty is bringing regenerative ingredients into everyday skincare, while DIY peptide culture is pushing experimentation further outside traditional healthcare. Together, they show how the desire to stay young is increasingly being shaped by beauty culture, self-optimization and declining trust in mainstream health.

Peptides rarely travel alone. As consumer interest in ingredients grows, peptides are pulling other compounds into the conversation, offering us a useful glimpse of what consumers may latch onto next. To understand where that interest is heading, we identified the top ingredients appearing in the peptide conversation using our autonomous research agent.

Skincare is already becoming a crowded ingredient race. Hyaluronic acid is up 35%, KPV 27% and niacinamide 15%, while copper peptides are growing 14%. PDRN/polynucleotides are down 9% and exosomes 48%, showing how quickly attention can move between ingredients even within regenerative beauty. Consumers are increasingly following ingredients themselves, moving between products based on the benefits and efficacy they associate with each one.

Outside skincare, the acceleration gets much more peptide-heavy. Weight loss is almost entirely peptide-driven, with retatrutide up 61%, semaglutide 53% and tirzepatide 35%. In performance, optimization communities are driving interest in compounds like TB-500 (+72%) and BPC-157 (+56%), while Semax/Selank is surging 197% in longevity.

Anti-aging sits somewhere between these worlds. Argireline/Matrixyl is up 100%, making it the fastest-growing ingredient in the category, while collagen peptides rise 23%. The numbers suggest that the appetite for peptide-like solutions is reaching beyond newer compounds and into more familiar anti-aging ingredients.

For brands, the opportunity may be in understanding what makes consumers suddenly flock to a specific ingredient, and what that curiosity could lead them to explore next.

The peptide conversation is opening up quickly, but not every part of it is equally ready for brands. Beauty is the clearest territory to build in now, while longevity, hair and next generation weight loss offer opportunities to get ahead. The more experimental injectable space is growing too, but brings a very different set of risks. Across the market, the brands with the strongest footing will be those that build credibility before they chase scale.

Peptides may not be the destination so much as a signpost. Beauty, longevity, weight loss and performance are increasingly converging around a broader appetite for optimization: looking better, feeling better and staying that way for longer. Public attention will inevitably move on to the next ingredient, but these underlying interests are likely to persist. The opportunity for brands is therefore less about owning peptides than understanding the needs and communities that peptides currently bring together.